Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-12-04
2008-08-05
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S199000, C544S371000, C548S360500, C540S575000, C514S218000, C514S253030, C514S407000
Reexamination Certificate
active
07407971
ABSTRACT:
A new class of pyrazolo derivative compounds having the formulawhere R and R1have the meanings given herein. The pyrazolo derivative compounds are useful in treating cell proliferative disorders caused by and/or associated with an altered cell cycle dependent kinase activity in mammals. The compounds may be provided in pharmaceutical compositions or in a kit.
REFERENCES:
patent: 2003/0171357 (2003-09-01), Fancelli et al.
Amici Raffaella
Brasca Maria Gabriella
Fancelli Daniele
Nesi Marcella
Orsini Paolo
Aulakh Charanjit S
Pfizer Italia S.r.l.
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
Substituted pyrrolo-pyrazole derivatives as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrrolo-pyrazole derivatives as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrrolo-pyrazole derivatives as kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4004998